|
Revvity
bw124734 ![]() Bw124734, supplied by Revvity, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bw124734/product/Revvity Average 92 stars, based on 1 article reviews
bw124734 - by Bioz Stars,
2026-02
92/100 stars
|
Buy from Supplier |
|
AMS Biotechnology
b16 f10 cells ![]() B16 F10 Cells, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16 f10 cells/product/AMS Biotechnology Average 96 stars, based on 1 article reviews
b16 f10 cells - by Bioz Stars,
2026-02
96/100 stars
|
Buy from Supplier |
|
Exosome Diagnostics
b16 f10 ![]() B16 F10, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16 f10/product/Exosome Diagnostics Average 93 stars, based on 1 article reviews
b16 f10 - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
Korean Cell Line Bank
b16f10 melanoma cells ![]() B16f10 Melanoma Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16f10 melanoma cells/product/Korean Cell Line Bank Average 90 stars, based on 1 article reviews
b16f10 melanoma cells - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Pasteur Institute
melanoma cell line b16f10 ![]() Melanoma Cell Line B16f10, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/melanoma cell line b16f10/product/Pasteur Institute Average 90 stars, based on 1 article reviews
melanoma cell line b16f10 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
CH Instruments
b16-f10 neoantigen peptides ![]() B16 F10 Neoantigen Peptides, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16-f10 neoantigen peptides/product/CH Instruments Average 90 stars, based on 1 article reviews
b16-f10 neoantigen peptides - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
BIOCYTOGEN ltd
b-luciferase b16-f10 ![]() B Luciferase B16 F10, supplied by BIOCYTOGEN ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b-luciferase b16-f10/product/BIOCYTOGEN ltd Average 90 stars, based on 1 article reviews
b-luciferase b16-f10 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Interlab Inc
human melanoma cell line sk-mel - 28 ![]() Human Melanoma Cell Line Sk Mel 28, supplied by Interlab Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human melanoma cell line sk-mel - 28/product/Interlab Inc Average 90 stars, based on 1 article reviews
human melanoma cell line sk-mel - 28 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Labec Inc
b16f10-nex2 cell line ![]() B16f10 Nex2 Cell Line, supplied by Labec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16f10-nex2 cell line/product/Labec Inc Average 90 stars, based on 1 article reviews
b16f10-nex2 cell line - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Institut Curie
b16-f10-ova melanoma cell line ![]() B16 F10 Ova Melanoma Cell Line, supplied by Institut Curie, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16-f10-ova melanoma cell line/product/Institut Curie Average 90 stars, based on 1 article reviews
b16-f10-ova melanoma cell line - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Cell Genesys
b16-f10 melanoma tumor cell line ![]() B16 F10 Melanoma Tumor Cell Line, supplied by Cell Genesys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16-f10 melanoma tumor cell line/product/Cell Genesys Average 90 stars, based on 1 article reviews
b16-f10 melanoma tumor cell line - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Genechem
cell line b16/f10 ![]() Cell Line B16/F10, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cell line b16/f10/product/Genechem Average 90 stars, based on 1 article reviews
cell line b16/f10 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell reports
Article Title: Chronic stress physically spares but functionally impairs innate-like invariant T cells
doi: 10.1016/j.celrep.2021.108979
Figure Lengend Snippet:
Article Snippet: Mouse: B16-F10-Red-FLuc (B16-FLuc) melanoma cells ,
Techniques: Control, Recombinant, Western Blot, Enzyme-linked Immunosorbent Assay, Staining, In Situ, Selection, cDNA Synthesis, Software
Journal: Journal of controlled release : official journal of the Controlled Release Society
Article Title: Surface Engineering Tumor Cells with Adjuvant-loaded Particles for Use as Cancer Vaccines
doi: 10.1016/j.jconrel.2016.12.036
Figure Lengend Snippet: (A1) B16.F10 cells and (A2) RM11 cells treated or not treated (control) with biotinylated anti-CD29 antibodies (anti-CD29-biotin) followed by strepavidin-PE. (B–F) Validation of cell-particle hybrid assembly from B16.F10 or RM11 cells subsequent to surface biotinylation using anti-CD29-biotin and mixed with streptavidin-coated particles loaded with rhodamine B and washed to remove unbound particles (hybrid). Control involved the same conditions except cells were not treated with anti-CD29-biotin. Validation was performed using: (B1–2 and E1–2): flow cytometry where (B1 and E1) representive (n = 1) and (B2 and E2) mean (n = 3) results from measuring relative mean rhodamine fluorescence intensity (RMFI(Rh)) of (B1 and B2) B16.F10 and (E1 and E2) RM11 cells; (C1–2 and F1–2): laser scanning confocal microscopy showing (C1 and F1) hybrid and (C2 and F2) control cell-particle mixtures for (C1 and C2) B16.F10 and (F1 and F2) RM11 cells (blue = DAPI stained cell nuclei, red = rhodamine-labeled PLGA particles); (D): scanning electron microscopy showing (D1) B16.F10 hybrid and (D2) control cell-particle mixtures (arrows in C1, D1, and F1 indicate particles bound to cell surface). Scale bar= 20 micron for C1–2 and F1–2, 10 microns for D1–2. When applicable, error bars = SD. ** p < 0.01, *** p < 0.001, n = 3.
Article Snippet: For vaccinations, a B16.F10 GM-CSF clone expressing 220 ng GM-CSF/10 6 cells/day was derived by transducing
Techniques: Flow Cytometry, Fluorescence, Confocal Microscopy, Staining, Labeling, Electron Microscopy
Journal: Journal of controlled release : official journal of the Controlled Release Society
Article Title: Surface Engineering Tumor Cells with Adjuvant-loaded Particles for Use as Cancer Vaccines
doi: 10.1016/j.jconrel.2016.12.036
Figure Lengend Snippet: Laser scanning confocal microscopy imaging of cell-particle hybrid uptake by BMDC. Cell-particle hybrids were incubated with BMDC Yellow arrows indicating colocalization of B16.F10 cells (green) and particles (red) inside BMDC (magenta). Magenta: Alexa flour®700 (CD11c) stained BMDC, green: CFSE labeled B16.F10 melanoma cells, red: rhodamine B-labeled PLGA particles, gray: DAPI stained cell nuclei. Scale bar: 20 micron.
Article Snippet: For vaccinations, a B16.F10 GM-CSF clone expressing 220 ng GM-CSF/10 6 cells/day was derived by transducing
Techniques: Confocal Microscopy, Imaging, Incubation, Staining, Labeling
Journal: Research in Pharmaceutical Sciences
Article Title: Antiangiogenic and antiproliferative effects of black pomegranate peel extract on melanoma cell line
doi:
Figure Lengend Snippet: The effects of PPE on cell viability. As detailed in Materials and methods, A; C554 HUVECs, B; B16F10 melanoma cells were treated with PPE and the viability of cells was determined by the MTT assay. The data are expressed as the percentage of cell viability compare to control.
Article Snippet: The human umbilical vein endothelial cells (HUVECs) (C554) and
Techniques: MTT Assay, Control
Journal: Frontiers in Immunology
Article Title: Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis
doi: 10.3389/fimmu.2020.00806
Figure Lengend Snippet: The deficiency of Bcl6 in Treg cells leads to delayed tumor progression. (A) RT-qPCR of Bcl6 expression in tumor infiltrating Treg (CD4 + CD25 + GITR + CXCR5 – , noted as TIL Treg) cells, Tfh (gated in CD4 + CD44 + Foxp3 – CXCR5 + ) and Th1 (gated in CD4 + CD44 + Foxp3 – CXCR5 – ) cells sorted from draining lymph node of WT tumor bearing mice. Naive CD4 (gated in CD4 + CD44 – ) sorted from naive WT mice are included as control. Mice were inoculated with 5 × 10 5 B16-F10 cells per mice intravenously, and were sacrificed (indicated as “Sac” in figure) at day 16 for analysis. The data presented are representative of two technical replicates pooled from at least three mice per group. (B) Bcl6 expression in tumor infiltrating Treg, dLNs Treg and spleen Treg (CD4 + CD25 + ) cells. Bcl6-RFP reporter mice were inoculated with 1 × 10 6 MC-38 subcutaneously, and were sacrificed at day 10 for flow cytometry analysis. Statistical analysis shown on the right. The data presented are representative of two independent experiments with at least three mice per group. Error bars indicate the mean ± SEM. * p < 0.05, *** p < 0.001. (C,D) Pictures of MC-38 tumor samples harvested at day 17 after tumor implantation [1 × 10 6 MC-38 cells per mice subcutaneously, panel (C) ], with tumor growth curve and weight (D) . (E) Tumor progression screened by bioluminescent imaging at D11. Mice were inoculated with 5 × 10 5 B16-F10 with luciferase sequence intravenously per mice. (F) Pictures of lung samples harvested from metastasis model, in which mice were inoculated with 1 × 10 6 B16-F10 cells per mice intravenously and sacrificed at day 16, with foci numbers calculated. (G) Survival curve of Bcl6 fl/fl Foxp3 Cre and WT mice inoculated with 5 × 10 5 B16-F10 per mice intravenously. Data were collected from 8 to 14 mice per group with two independent experiments. Statistical differences were calculated by unpaired t -test (tumor weight), Log-rank test (survival curve) or two-way ANOVA with a post hoc Turkey test (tumor growth curve). *** p < 0.001, **** p < 0.0001. Data are presented as mean ± SEM. See also .
Article Snippet: Tumor cell lines,
Techniques: Quantitative RT-PCR, Expressing, Flow Cytometry, Tumor Implantation, Imaging, Luciferase, Sequencing
Journal: Frontiers in Immunology
Article Title: Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis
doi: 10.3389/fimmu.2020.00806
Figure Lengend Snippet: Tfr cells are dispensable for tumor control. (A) Set up of Tfr deficient Bone Marrow Chimera mice. Bone marrow cells were isolated from Foxp3 DTR and Cxcr5 –/– mice were mixed 1:1 and then transferred 8 × 10 6 per mice to irradiated CD4 –/– mice. After reconstruction, mice were inoculated with 5 × 10 5 B16-F10 cells intravenously and were treated with DT or vehicle, then sacrificed at D16 post tumor inoculation. (B) Pictures of lung samples harvested from metastasis model of Tfr deficient mice. (C–E) Flow cytometry analyzing proportion and total number of Treg, Tfr, Tfh, Th1, CD8 + CXCR5 + subpopulation from dLNs (C) and Treg, CD4 + CD44 – (D) , CD8 + T cells (E) from tumor tissue. The data presented are representative of two independent experiments with at least 4 mice per group. # represents the absolute number and % represents the proportion of indicating population. Statistical differences were calculated by unpaired t -test. Center values indicate mean. See also .
Article Snippet: Tumor cell lines,
Techniques: Isolation, Irradiation, Flow Cytometry
Journal: Frontiers in Immunology
Article Title: Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis
doi: 10.3389/fimmu.2020.00806
Figure Lengend Snippet: Bcl6 is essential in maintaining the lineage stability of Treg cells in TME. (A) RT-qPCR analysis of Foxp3 expression, normalized to its expression in Bcl6-deficient tumor infiltrating Treg cells (CD4 + CD25 + GITR + CXCR5 – ), assessed at day 16 after B16-F10 inoculation intravenously. (B) RT-qPCR analysis of Foxp3 expression, normalized to its expression in Treg cells (CD4 + CD25 + GITR + CXCR5 – ) from spleen, mesenteric lymph nodes(mLN) or peripheral non-draining lymph nodes (pLN) of naive Bcl6 fl/fl Foxp3 Cre and WT mice. (C,D) RT-qPCR analysis of Gata3 and Il4 (C) , Il17 and Rorc (D) normalized to their expression in Bcl6-deficient and WT tumor infiltrating Treg cells (CD4 + CD25 + GITR + CXCR5 – ). Naive CD4 (gated in CD4 + CD44 – ) sorted from naive WT mice, Tfh (gated in CD4 + CD44 + Foxp3 – CXCR5 + ) and Th1 (gated in CD4 + CD44 + Foxp3 – CXCR5 – ) cells sorted from WT mice infected with Armstrong (Arm) at day 8 are included as control. (E) RT-qPCR analysis of Il17 , Rorc and Gata3 normalized to their expression in Treg cells (CD4 + CD25 + GITR + CXCR5 – ) from spleen, mesenteric lymph nodes(mLN) or peripheral non-draining lymph nodes (pLN) of naive Bcl6 fl/fl Foxp3 Cre and WT mice. The data (A-E) presented are representative of two technical replicates pooled from at least three mice per group. Error bars indicate the mean ± SEM. (F) Flow cytometry analysis of tumor infiltrating Treg cells in splenic chimera mice assay, assessed at day 18 after B16-F10 inoculation intravenously. Quantification of Tbet and GATA3 in Bcl6-deficient and WT Treg cells. The data presented are representative of two independent experiments with at least 4 mice per group. Statistical differences were calculated by paired t -test. ** p < 0.01, **** p < 0.0001.
Article Snippet: Tumor cell lines,
Techniques: Quantitative RT-PCR, Expressing, Infection, Flow Cytometry, Mouse Assay